| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |